So, FY2018 EBIT up 17% on FY2017's EBIT (and FY2017 was not exactly a depressed starting base, with EBIT for that year being up 49% on FY2016).
It is fair to say the business is travelling along just fine.
Assuming - conservatively - a further 7%-8% NPAT growth in FY2019, the implied prospective valuation for of the stock is ~15x P/E and 9.5x EV/EBITDA.
Which feels appropriate, fair and reasonable to me.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$37.51 |
Change
0.090(0.24%) |
Mkt cap ! $1.630B | |||
| Open | High | Low | Value | Volume |
| $38.91 | $38.91 | $37.21 | $1.725M | 45.79K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 211 | $37.47 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $37.73 | 211 | 1 |
View Market Depth
| Last trade - 16.10pm 17/06/2025 (20 minute delay) ? |
| SNL (ASX) Chart |